These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9131861)

  • 1. Symptomatic carriers of muscular dystrophy.
    Azam M
    J Pak Med Assoc; 1997 Mar; 47(3):89-93. PubMed ID: 9131861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy].
    Moser H; Mumenthaler M; Wiesmann U
    Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948
    [No Abstract]   [Full Text] [Related]  

  • 5. Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.
    Verrill HL; Pickard NA; Gruemer HD
    Clin Chem; 1977 Dec; 23(12):2341-3. PubMed ID: 923085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular dystrophy. Part II: Serum enzymes in relatives of cases of the Duchenne muscular dystrophy.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):605-11. PubMed ID: 4435869
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of young female carriers of Duchenne muscular dystrophy].
    Alvarez Leal MA; Morales-Aguilera A
    Arch Invest Med (Mex); 1990; 21(3):269-72. PubMed ID: 2131776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum alpha-galactosidase activity in children with Duchenne-type muscular dystrophy and in gene carriers.
    László A; Havass Z
    Acta Paediatr Hung; 1983; 24(4):327-9. PubMed ID: 6324830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 13. Female carriers of Duchenne muscular dystrophy: a dilemma.
    Isaacs H; Badenhorst M
    Clin Genet; 1987 May; 31(5):288-96. PubMed ID: 3608214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Becker-type muscular dystrophy.
    Bradley WG; Jones MZ; Mussini JM; Fawcett PR
    Muscle Nerve; 1978; 1(2):111-32. PubMed ID: 571527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales.
    Norman A; Harper P
    Clin Genet; 1989 Jul; 36(1):31-7. PubMed ID: 2766561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers.
    Wenger SL; Steele MW; Hoffman EP; Barmada MA; Wessel HB
    Am J Med Genet; 1992 Aug; 43(6):1012-5. PubMed ID: 1415326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Muscular dystrophy: Duchenne and Becker-Kiener types].
    Kuhn E
    Dtsch Med Wochenschr; 1979 Dec; 104(51):1817-20. PubMed ID: 391521
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 20. X-linked Duchenne muscular dystrophy in an unusual family with manifesting carriers.
    Kaladhar Reddy B; Anandavalli TE; Reddi OS
    Hum Genet; 1984; 67(4):460-2. PubMed ID: 6490012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.